ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
PharmaTher Holdings Ltd

PharmaTher Holdings Ltd (PHRM)

0.22
0.00
( 0.00% )
Actualizado: 08:29:57

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.22
Postura de Compra
0.21
Postura de Venta
0.225
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.17 Rango de 52 semanas 0.43
Precio Anterior
0.22
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
72,837
Volumen financiero
-
Precio Promedio Ponderado
-

PHRM Últimas noticias

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

 PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch Delivering psilocybin via microneedle patch unlocks potential for desired dosage forms and pharmacokinetic profiles...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

 PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch  Focusing on partnership model for MicroDose-MN™ and...

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

 PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Leading U.S.-based CDMO to manufacture PharmaTher's proprietary ketamine products for FDA Phase 3...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome Achieving its second FDA orphan drug designation with ketamine.Building a proprietary...

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund

 PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund TORONTO, September 21, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings Ltd. (the...

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

  PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022   10 clinical sites selected to participate in the FDA Phase 2 clinical...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis Focusing on becoming a global leader in prescription-based ketamine productsAdvancing to a Phase...

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

 PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Strengthens position to become a leader in the intradermal delivery of FDA...

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

  PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression   Potential for FDA 505(b)(2) regulatory pathway approval and...

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease

  PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease   TORONTO, May 25, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.014.76190476190.210.2250.2379710.22167374CS
40.0052.325581395350.2150.2350.19471730.21665589CS
120.0052.325581395350.2150.280.19728370.22878235CS
26-0.005-2.222222222220.2250.330.18814510.23812425CS
52-0.035-13.72549019610.2550.430.17837930.24645835CS
156-0.02-8.333333333330.240.430.0551007960.18561508CS
260-0.035-13.72549019610.2551.240.051984880.34801235CS

PHRM - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de PharmaTher?
El precio actual de las acciones de PharmaTher es $ 0.22
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de PharmaTher?
PharmaTher ha negociado en un rango de $ 0.17 a $ 0.43 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLKMMayo Lake Minerals Inc
$ 0.035
(133.33%)
13k
BHCCBlue Horizon Global Capital Corp
$ 0.01
(100.00%)
4k
IANiAnthus Capital Holdings Inc
$ 0.01
(100.00%)
25k
AWRAurwest Resources Corporation
$ 0.01
(100.00%)
3k
CODECypher Metaverse Inc
$ 3.72
(86.00%)
90.18k
SURESureNano Science Ltd
$ 0.065
(-55.17%)
33k
DDDouble Deuce Exploration Corp
$ 0.11
(-54.17%)
1,000
ARMArmada Mercantile Ltd
$ 0.215
(-50.57%)
4.38k
CCRGreen River Gold Corp
$ 0.005
(-50.00%)
2k
TUGATuga Innovations Inc
$ 0.01
(-50.00%)
62k
NFLDExploits Discovery Corp
$ 0.04
(0.00%)
2.59M
ONCOOnco Innovations Limited
$ 2.37
(7.73%)
2.13M
VTALJustera Health Ltd
$ 0.01
(0.00%)
1.23M
BCBCBC Bud Corporation
$ 0.145
(3.57%)
1.16M
TNJBoba Mint Holdings Ltd
$ 0.34
(13.33%)
1.15M
luckydude777 luckydude777 2 minutos hace
Got some shares of ALLR for sale at $20 minimum.
ALLR
Investor082 Investor082 2 minutos hace
I agree. They don’t the team to even manage $5M in annual revenue. When will hiring start to support increase in revenue going from $1.5M in Specials revenue to say even $10M? LP does not believe they have a shot at meaningful revenue uptick in the first year without reimbursement support. Otherwise
NWBO
martyDg martyDg 2 minutos hace
No you're just gullible to think that yesterday was different from the rest of the pump. idiot
NWBO
Viking61 Viking61 2 minutos hace
Brooge, were you able to get back in, in the 4s?
FNMA
jimr1717 jimr1717 2 minutos hace
.00000000000001 Soon Shrimpscam
SHMP
KellySueNews KellySueNews 2 minutos hace
Everyone see Venture Global's IPO today?  $25 a share.....
TGLO
fwb fwb 2 minutos hace
AWS and Booz Allen Announce Expanded Partnership to Speed Digital Transformation for U.S. Federal Agencies
January 24 2025 - 6:45AM
Business Wire
Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and Booz Allen Hamilton (NYSE: BAH) today announced an expan
AMZN
kittycattttt kittycattttt 2 minutos hace
How is it blue sky when .0013 was already tested?
TKMO
EmpressMonk25 EmpressMonk25 2 minutos hace
Not so, as they are indeed part of the HUMBL assets.
HMBL
Fdc4 Fdc4 2 minutos hace
I don’t think they need to clarify beyond. What I do believe is that you need to practice on understanding such more. I only want to know who has it, what is the time frame of the unlock and at what price. Not sure what you mean on need to clarify more on such. None sense
SMCE
subslover subslover 3 minutos hace
Sweet! GO FOR IT!♥️
PRFX
GrantHorvat1 GrantHorvat1 3 minutos hace
It will be better than blockchain. It will be crypto itself.

And the crypto rocket launch is just beginning to fire up.

Sharp learned his lessons last time around. He won't be making the same mistakes again.

By May this will be at all time highs of at lea
GVSI
Monksdream Monksdream 3 minutos hace
SOFI, new 52=high
https://investorshub.advfn.com/uimage/uploads/2025/1/24/ajtrsIMG_4768.gif
SOFI
siar siar 3 minutos hace
If @Juststoppingby is right in post #44864, CRTG owns 22.31%.
That means that revenue and earnings do not apply to CRTG. It's just the group's revenue and earnings of which CRTG can show 22.31% in it's financial statements.

And something seems to be strange to me. How much did
CRTG
scottyb scottyb 3 minutos hace
down down it goes weeee
VRSSF
PickStocks PickStocks 3 minutos hace
Reach 110.....break to 120 will happen...
COOP
ORCA ORCA 3 minutos hace
10-K IS OUT TODAY.READ BOLD.LAST PART TOO.
https://www.otcmarkets.com/otcapi/company/financial-report/420617/content
IP valuation: The current IP portfolio has a market value of around $2.5 to $3.0M and with the addition of the
Provisional Patent and expected issuance of a full
BSTK
Huggy Bear Huggy Bear 3 minutos hace
And why do you believe these assets will return?
HMBL
CHARLIESAN CHARLIESAN 3 minutos hace
Steady and slow growth is good growth.
You want good management; a strength here.
I see this as a strong conviction play.
BYD
NewJerichoMan NewJerichoMan 3 minutos hace
Who can buy 100K shares on the Expert Market?
ASKH
linkvest linkvest 3 minutos hace
Slapped it again on the 6s... I'm done for the day...
ASII
tulla236a tulla236a 3 minutos hace
so here is the new rev repos???

https://www.newyorkfed.org/markets/desk-operations/reverse-repo
AMC
k9narc k9narc 3 minutos hace
If you use kosher salt in a measured recipe, go by weight (grams) and not volume (TSP)
Kosher salt can weigh 30 less in equal volume.

I think I have 10 or more different types of salt.
I cold smoke both kosher and sea salt . Best salts ever.

https://invest
West2 West2 4 minutos hace
DRGV will surprise people 
The waiting is over 
2025 the year of the dragon 
https://www.dragoncapital.com/

DRGV

Su Consulta Reciente

Delayed Upgrade Clock